Skip to main content

Insight Molecular Diagnostics Inc.

IMDX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
SEC CIK
0001642380

No open-market purchases or sales by Insight Molecular Diagnostics Inc. insiders were filed in the last 90 days; 43 institutions reported holding it in 13F filings for Q3 2026, worth $66.6M in total; no superinvestor holds it.

Holders of 5% or more of IMDX

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Insight Molecular Diagnostics Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of IMDX
HolderLatest formStakeChangeFirst filedLatest filingFiling
Broadwood Partners, L.P.13D/A39.70%12.8M shares+2.30 ppfrom 37.40%Jan 22, 202110 filingsApr 27, 2026SEC
Smith Patrick W13G/A10.50%1.77M shares–Oct 9, 20243 filingsDec 27, 2024SEC
AWM Investment Company, Inc.13G/A10.00%2.86M shares+2.50 ppfrom 7.50%Feb 14, 20234 filingsMay 9, 2025SEC
Bio-Rad Laboratories, Inc.13G/A9.70%2.76M shares–Apr 22, 20243 filingsMar 4, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

33 Schedule 13D and 13G filings on Insight Molecular Diagnostics Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on IMDX
Filed (ET)FilerFormStakeChangeEvent dateFiling
Apr 27, 20267:14 PM ETBroadwood Partners, L.P.and 2 others13D/A39.70%12.8M shares+2.30 ppfrom 37.40%Apr 23, 2026SEC
Feb 12, 20267:52 PM ETBroadwood Partners, L.P.and 2 others13D/A37.40%12.1M shares−2.80 ppfrom 40.20%Feb 10, 2026SEC
May 9, 20254:06 PM ETAWM Investment Company, Inc.13G/A10.00%2.86M shares+2.50 ppfrom 7.50%Mar 31, 2025SEC
Mar 4, 20257:06 PM ETBio-Rad Laboratories, Inc.13G/A9.70%2.76M shares–Feb 10, 2025SEC
Feb 14, 20252:41 PM ETAWM Investment Company, Inc.13G/A7.50%1.31M shares–Dec 31, 2024SEC
Feb 10, 20258:46 PM ETBroadwood Partners, L.P.and 2 others13D/A40.20%11.6M shares–Feb 6, 2025SEC
Dec 27, 20249:58 PM ETSmith Patrick Wand 1 other13G/A10.50%1.77M shares–Dec 26, 2024SEC
Dec 9, 2024Smith Patrick W13G/AOld format–––SEC
Nov 14, 2024Pura Vida Investments, LLC13GOld format–––SEC
Oct 24, 2024Bio-Rad Laboratories, Inc.13G/AOld format–––SEC
Oct 9, 2024Smith Patrick W13GOld format–New–SEC
Apr 22, 2024Bio-Rad Laboratories, Inc.13GOld format–New–SEC
Apr 15, 2024Broadwood Partners, L.P.13D/AOld format–––SEC
Feb 14, 2024Pura Vida Investments, LLC13G/AOld format–––SEC
Feb 14, 2024AWM Investment Company, Inc.13G/AOld format–––SEC
Apr 14, 2023Pura Vida Investments, LLC13G/AOld format–––SEC
Apr 7, 2023Broadwood Partners, L.P.13D/AOld format–––SEC
Feb 14, 2023Pura Vida Investments, LLC13G/AOld format–––SEC
Feb 14, 2023Pura Vida Investments, LLC13GOld format–––SEC
Feb 14, 2023AWM Investment Company, Inc.13GOld format–New–SEC
Nov 25, 2022Norfield Capital LLC13GOld format–New–SEC
Jul 28, 2022Broadwood Partners, L.P.13D/AOld format–––SEC
May 9, 20223:23 PM ETBlackRock Inc.13GOld format–––SEC
Apr 18, 2022Halle Special Situations Fund LLC13GOld format–New–SEC
Apr 15, 2022Broadwood Partners, L.P.13D/AOld format–––SEC
Feb 4, 20224:12 PM ETBlackRock Inc.13GOld format–––SEC
Sep 24, 2021Broadwood Partners, L.P.13D/AOld format–––SEC
Feb 10, 20213:04 PM ETBlackRock Inc.13G/AOld format–––SEC
Feb 9, 2021Broadwood Partners, L.P.13D/AOld format–––SEC
Feb 2, 20213:13 PM ETBlackRock Inc.13GOld format–New–SEC
Jan 28, 2021Pura Vida Investments, LLC13G/AOld format–––SEC
Jan 22, 2021Broadwood Partners, L.P.13D/AOld format–––SEC
Jan 8, 20215:00 PM ETLineage Cell Therapeutics, Inc.13D/AOld format–––SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Insight Molecular Diagnostics Inc. shares.

No Form 144 notices for Insight Molecular Diagnostics Inc. are on file.